Investing in Active Lifestyles & Healthy Living April 20 & 21, 2016 TSXV: RLV ● FRA: 6BX
THIS DOCUMENT HAS BEEN PREPARED BY RELEVIUM TECHNOLOGIES INC. (THE “COMPANY”) SOLELY FOR INFORMATION PURPOSES. THIS DOCUMENT DOES NOT CONSTITUTE AN OFFERING DOCUMENT. THIS DOCUMENT IS THE SOLE RESPONSIBILITY OF THE COMPANY. INFORMATION CONTAINED HEREIN DOES NOT PURPORT TO BE COMPLETE AND IS SUBJECT TO CERTAIN QUALIFICATIONS AND ASSUMPTIONS AND SHOULD NOT BE RELIED UPON FOR THE PURPOSE OF MAKING AN INVESTMENT IN THE COMPANY’S SECURITIES OR ENTERING INTO ANY TRANSACTION IN RELATION THEREWITH. THE INFORMATION AND OPINIONS CONTAINED IN THIS DOCUMENT ARE PROVIDED AS AT THE DATE HEREOF AND ARE SUBJECT TO CHANGE WITHOUT NOTICE AND, IN FURNISHING THIS DOCUMENT, THE COMPANY DOES NOT UNDERTAKE OR AGREE TO ANY OBLIGATION TO PROVIDE RECIPIENTS WITH ACCESS TO ANY ADDITIONAL INFORMATION OR TO UPDATE OR CORRECT THE DOCUMENT. THIS DOCUMENT, NOR HAS IT REVIEWED THIS DOCUMENT. FORWARD LOOKING INFORMATION CERTAIN OF THE INFORMATION CONTAINED IN THIS PRESENTATION MAY CONTAIN “FORWARD -LOOKING INFORMATION” . FORWARD-LOOKING INFORMATION AND STATEMENTS MAY INCLUDE, AMONG OTHERS, STATEMENTS REGARDING THE FUTURE PLANS, COSTS, OBJECTIVES OR PERFORMANCE OF THE COMPANY, OR THE ASSUMPTIONS UNDERLYING ANY OF THE FOREGOING. IN THIS PRESENTATION, WORDS SUCH AS “MAY”, “WOULD”, “COULD”, “WILL”, “LIKELY”, “BELIEVE”, “EXPECT”, “ANTICIPATE”, “INTEND”, “PLAN”, “ESTIMATE” AND SIMILAR WORDS AND THE NEGATIVE FORM THEREOF ARE USED TO IDENTIFY FORWARD-LOOKING STATEMENTS. FORWARD-LOOKING STATEMENTS SHOULD NOT BE READ AS GUARANTEES OF FUTURE PERFORMANCE OR RESULTS, AND WILL NOT NECESSARILY BE ACCURATE INDICATIONS OF WHETHER, OR THE TIMES AT OR BY WHICH, SUCH FUTURE PERFORMANCE WILL BE ACHIEVED. FORWARD-LOOKING STATEMENTS AND INFORMATION ARE BASED ON INFORMATION AVAILABLE AT THE TIME AND/OR MANAGEMENT’S GOOD-FAITH BELIEF WITH RESPECT TO FUTURE EVENTS AND ARE SUBJECT TO KNOWN OR UNKNOWN RISKS, UNCERTAINTIES, ASSUMPTIONS AND OTHER UNPREDICTABLE FACTORS, MANY OF WHICH ARE BEYOND THE COMPANY’S CONTROL. THE COMPANY DOES NOT INTEND, NOR DOES THE COMPANY UNDERTAKE ANY OBLIGATION, TO UPDATE OR REVISE ANY FORWARD-LOOKING INFORMATION OR STATEMENTS CONTAINED IN THIS PRESENTATION TO REFLECT SUBSEQUENT INFORMATION, EVENTS OR CIRCUMSTANCES OR OTHERWISE, EXCEPT IF REQUIRED BY APPLICABLE LAWS.
About our Company ABOUT US
ABOUT US “It is the Mission of Relevium Technologies to invest in Knowledge, Products and Services in the Health and Wellness Space, with particular focus on Pain Management, Quick Recovery and Optimal Performance. We create value by consolidating unique products and services for our customers: the progressive health and wellness consumers” TSXV:RLV ● FRA:6BX
ABOUT US Investing in Active Lifestyles & Healthy Living PAIN MANAGEMENT Pain avoidance is one of the most important drivers of consumer behavior worldwide. The market for pain relief is estimated to be about $39 billion in and it is expected to reach $41.5 billion in 2017 with a compound annual growth of over 5%*. The primary focus of Relevium in this vertical segment is on wearable devices that reduce musculoskeletal pain caused by injuries or mechanical dysfunction. TSXV:RLV ● FRA:6BX TSXV:RLV ● FRA:6BX *http://www.bccresearch.com/market-research/healthcare/pain-management-drugs-devices-hlc026d.html
ABOUT US Investing in Active Lifestyles & Healthy Living RECOVERY Musculoskeletal injuries such as sprains and strains are among the most common and costly burdens to the medical system and workforce. Direct costs (medical expenses) related to injuries are estimated at $190 billion per year and indirect costs (loss in wages) $120 billion per year. The Integrated Benefits Institute suggest that for every 100 employees the costs to companies amounts to $103,000 per year.* The primary focus of Relevium in this vertical segment is on wearable technologies that reduce recovery times in treating musculoskeletal injuries. *http://www.theworkfoundation.com/DownloadPublication/Report/385_White%20paper%20- TSXV:RLV ● FRA:6BX %20Musculoskeletal%20disorders%20workforce%20health%20and%20productivity%20in%20the%20USA%20final.pdf
ABOUT US Investing in Active Lifestyles & Healthy Living PERFORMANCE Traditionally under the global sports apparel market and encompassing over $135 billion of business in 2012, Performance has widened in scope to include Nutrition and Mind. Driven by a growing fitness consciousness, living better and longer the market for performance enhancement is expected to drive market growth exponentially. The primary focus of Relevium in this vertical segment is on Nutraceuticals and Wearables that enhance overall performance and reduce recovery time. TSXV:RLV ● FRA:6BX
About our Company LEADERSHIP TEAM
LEADERSHIP TEAM Leena Lakdawala Director and CEO Leena Lakdawala is a senior executive with 22 years’ experience in the manufacturing and consumer product sector. Leena has served in several senior managerial roles in private and publicly held corporations, including Director of Administration, Director of Marketing, Vice-President of Operations and most recently Executive Vice-President. Leena serves on the board of several privately held companies and serves as an advisor to an early stage business venture. Leena is a graduate Executive MBA from Queens School of Business. Andre Godin Director and Chairman Andre Godin is currently Executive Vice-President & Chief Financial Officer at IntelGenx and has more than 25 years’ experience in the Biotech -Pharma industry. He has a strong background in Capital Markets, Finance and Operations. Mr. Godin held several high level positions as CEO, CFO and Vice- President of pharmaceutical and nutraceutical Companies. Mr. Godin is a member of the Canadian Chartered Professional Accountants and the Canadian Institute of Chartered Accountants. He holds a Bachelor of Business Administration degree from Université du Québec à Montreal. TSXV:RLV ● FRA:6BX
LEADERSHIP TEAM Kristine Dorward Director Kristine is Director of Marketing and Business Development at Prometic Life Sciences, joining the organization in 2014. Having worked in the pharmaceutical and biotechnology industry for more than 17 years, Kristine has held senior positions in licensing, acquisitions, marketing and sales with geographical scope encompassing both North American and global markets. Acting in strategic leadership roles, Kristine has contributed to the successful launch of products in multiple therapeutic areas and has completed numerous due diligence evaluations as part of pipeline planning and expansion efforts to drive corporate growth. Kristine holds an MBA, BSc, CLP designation with CVA credential in progress. Michel Timperio Director Michel currently holds the position of Head of Strategic Development at Neptune. He has been employed by Neptune since 2010, but was a member of the Board of Directors from 2000 to 2008. Mr. Timperio has many years of experience in sales. He obtained his Bachelor of Commerce at Concordia University in Montreal, Quebec. With a natural entrepreneurial character, he launched his own distributing business. Many years later, Mr. Timperio built a start-up venture in residential construction from 2001 – 2010. He has worked for large corporations, including Armstrong World Industries and Reichhold Chemicals, where he held senior management business development positions. Mr. Timperio has also retained a political career for six years. TSXV:RLV ● FRA:6BX
LEADERSHIP TEAM Ted Zablotsky, MD Director Ted Zablotsky, MD is co-founder and co-inventor of the US Patent acquired by the Company as part of the qualifying transaction of August 2015. Dr. Zablotsky has pioneered research and documentation of the effects of bio-magnetism on the body since 1985. A noted author and speaker, Dr. Zablotsky has been a driving force behind the clinical development, research and regulatory registrations that established the credibility of magnetic therapy. Dr. Zablotsky serves on the board of the Jewish Federation of Greater Hartford. Aurelio Useche MBA. CPA. CMA. ICD.D Providing guidance and support over the M&A activities of the company, Mr. Useche leverages over 20 years of senior management experience in private and publicly traded corporations including manufacturing, mining exploration and consumer products. Aurelio serves on the board of several private and public companies and holds an executive MBA from Queens School of Business he holds a CPA-CMA accreditation and is also a graduate of the Directors Program from the Rotman School of Business. TSXV:RLV ● FRA:6BX
Recommend
More recommend
